Skip to Content

Miacalcin Nasal (calcitonin) Disease Interactions

There is 1 disease interaction with Miacalcin Nasal (calcitonin):


Calcitonin (Includes Miacalcin Nasal) ↔ mineral metabolism disorders

Severe Potential Hazard, Moderate plausibility. Applies to: Hypocalcemia, Vitamin D Deficiency

When calcitonin is used for the treatment of osteoporosis, hypocalcemia and other disturbances of mineral metabolism such as vitamin D deficiency should be treated prior to initiation of therapy. The desired increase in bone mineral density requires an adequate supply of calcium and vitamin D in the body. In patients with these conditions, serum calcium and symptoms of hypocalcemia should be monitored during therapy with calcitonin salmon nasal spray. Appropriate intake of calcium and vitamin D should be ensured throughout the course of treatment.


  1. "Product Information. Calcimar (calcitonin)." Rhone-Poulenc Rorer, Collegeville, PA.
  2. "Product Information. Miacalcin Injection, Synthetic (calcitonin)." Novartis Pharmaceuticals, East Hanover, NJ.

Miacalcin Nasal (calcitonin) drug interactions

There are 6 drug interactions with Miacalcin Nasal (calcitonin)

Drug Interaction Classification

These classifications are only a guideline. The relevance of a particular drug interaction to a specific individual is difficult to determine. Always consult your healthcare provider before starting or stopping any medication.
Major Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit.
Moderate Moderately clinically significant. Usually avoid combinations; use it only under special circumstances.
Minor Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan.
Unknown No interaction information available.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.